1. Successful treatment of multinucleate cell angiohistiocytoma in an adult male patient with potassium-titanyl-phosphate laser in combination with intralesional corticosteroids
- Author
-
Bryn Edgerton, Charlene Hunter, Vimal H. Prajapati, Alim Devani, and Malika A. Ladha
- Subjects
medicine.medical_specialty ,potassium-titanyl-phosphate ,Adult male ,Potassium titanyl phosphate ,Case Report ,Spontaneous remission ,multinucleate cell angiohistiocytoma ,Dermatology ,Asymptomatic ,Pathogenesis ,fibrohistiocytic ,030207 dermatology & venereal diseases ,03 medical and health sciences ,chemistry.chemical_compound ,general dermatology ,0302 clinical medicine ,vascular ,medicine ,Potassium titanyl phosphate laser ,KTP, potassium-titanyl-phosphate ,dermatopathology ,ILC, intralesional corticosteroid ,business.industry ,MCAH, multinucleate cell angiohistiocytoma ,laser ,chemistry ,030220 oncology & carcinogenesis ,Multinucleate cell ,Dermatopathology ,medicine.symptom ,business - Abstract
Multinucleate cell angiohistiocytoma (MCAH) is a rare, benign, idiopathic disease characterized by strong female predominance and predilection for the extremities and face.1 Most often asymptomatic, MCAH follows an indolent, yet progressive course, with spontaneous remission being uncommon. Many aspects of this vascular and fibrohistiocytic proliferation are controversial, including pathogenesis and treatment recommendations. We present a case of MCAH in a male patient successfully treated with potassium-titanyl-phosphate (KTP) laser.
- Published
- 2019
- Full Text
- View/download PDF